Skip to content
Annalist
Companies Compare Method Data Quality For AI agents

Thermo Fisher Scientific Inc.

TMO · NYSE · Health care, life sciences tools · United States · US GAAP · Fiscal year ends December

Latest report: Q2 FY2026, the quarter ended 27 June 2026, released 31 July 2026. Snapshot FY2026Q2_1bcd94e5.

Overview

Revenue, quarter
+10.5% year on year
Operating income, quarter
+13.8% year on year
Net income, quarter
+7.4% year on year
Diluted EPS, quarter
+9.3% year on year
Operating margin, last 4 quarters
+0.4pp year on year
Return on equity, last 4 quarters
+0.1pp year on year

Select a figure to see the document it came from.

Key Findings

Findings for the latest quarter, with their history over earlier quarters.

  1. Revenue for the quarter ended 27 June 2026 was US$12.0 billion, 10.5% higher than in the same quarter a year earlier.

    Strengthenedin Q2 FY2026 · stated since Q3 FY2024
    Rule: Revenue against a year earlier · Sources 10-Q 2026-06
    History of this finding, 10 records
    1. Q2 FY2026 StrengthenedRevenue for the quarter ended 27 June 2026 was US$12.0 billion, 10.5% higher than in the same quarter a year earlier.Recorded from FY2026Q2_00b71dc7 · data update
    2. Q1 FY2026 WeakenedRevenue for the quarter ended 28 March 2026 was US$11.0 billion, 6.2% higher than in the same quarter a year earlier.Reconstructed · data update
    3. Q4 FY2025 StrengthenedRevenue for the quarter ended 31 December 2025 was US$12.2 billion, 7.2% higher than in the same quarter a year earlier.Reconstructed · data update
    4. Q3 FY2025 StrengthenedRevenue for the quarter ended 27 September 2025 was US$11.1 billion, 4.9% higher than in the same quarter a year earlier.Reconstructed · data update
    5. Q2 FY2025 StrengthenedRevenue for the quarter ended 28 June 2025 was US$10.9 billion, 3.0% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q1 FY2025 WeakenedRevenue for the quarter ended 29 March 2025 was US$10.4 billion, 0.2% higher than in the same quarter a year earlier.Reconstructed · data update
    7. Q4 FY2024 StrengthenedRevenue for the quarter ended 31 December 2024 was US$11.4 billion, 4.7% higher than in the same quarter a year earlier.Reconstructed · data update
    8. Q3 FY2024 NewRevenue for the quarter ended 28 September 2024 was US$10.6 billion, 0.2% higher than in the same quarter a year earlier.Reconstructed · data update
    9. Q3 FY2024 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    10. Q2 FY2024 NewRevenue for the quarter ended 29 June 2024 was US$10.5 billion, 1.4% lower than in the same quarter a year earlier.Reconstructed · initial
  2. Net income attributable to the company was US$1.7 billion, 7.4% higher than in the same quarter a year earlier.

    Weakenedin Q2 FY2026 · stated since Q4 FY2025
    Rule: Net income against a year earlier · Sources 10-Q 2026-06
    History of this finding, 13 records
    1. Q2 FY2026 WeakenedNet income attributable to the company was US$1.7 billion, 7.4% higher than in the same quarter a year earlier.Recorded from FY2026Q2_00b71dc7 · data update
    2. Q1 FY2026 StrengthenedNet income attributable to the company was US$1.7 billion, 9.6% higher than in the same quarter a year earlier.Reconstructed · data update
    3. Q4 FY2025 NewNet income attributable to the company was US$2.0 billion, 7.3% higher than in the same quarter a year earlier.Reconstructed · data update
    4. Q4 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    5. Q3 FY2025 NewNet income attributable to the company was US$1.6 billion, 0.9% lower than in the same quarter a year earlier.Reconstructed · data update
    6. Q3 FY2025 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    7. Q2 FY2025 WeakenedNet income attributable to the company was US$1.6 billion, 4.5% higher than in the same quarter a year earlier.Reconstructed · data update
    8. Q1 FY2025 StrengthenedNet income attributable to the company was US$1.5 billion, 13.5% higher than in the same quarter a year earlier.Reconstructed · data update
    9. Q4 FY2024 NewNet income attributable to the company was US$1.8 billion, 12.3% higher than in the same quarter a year earlier.Reconstructed · data update
    10. Q4 FY2024 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    11. Q3 FY2024 NewNet income attributable to the company was US$1.6 billion, 5.0% lower than in the same quarter a year earlier.Reconstructed · data update
    12. Q3 FY2024 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    13. Q2 FY2024 NewNet income attributable to the company was US$1.5 billion, 13.7% higher than in the same quarter a year earlier.Reconstructed · initial
  3. The operating margin over the last 4 quarters was 17.6%, 0.4 percentage points higher than a year earlier.

    Strengthenedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Operating margin against a year earlier · Sources 10-Q 2025-09, 10-K 2025-12, 10-Q 2026-03 and 1 more
    History of this finding, 9 records
    1. Q2 FY2026 StrengthenedThe operating margin over the last 4 quarters was 17.6%, 0.4 percentage points higher than a year earlier.Recorded from FY2026Q2_00b71dc7 · data update
    2. Q1 FY2026 ConfirmedThe operating margin over the last 4 quarters was 17.5%, 0.2 percentage points higher than a year earlier.Reconstructed · data update
    3. Q4 FY2025 ConfirmedThe operating margin over the last 4 quarters was 17.4%, 0.3 percentage points higher than a year earlier.Reconstructed · data update
    4. Q3 FY2025 ConfirmedThe operating margin over the last 4 quarters was 17.2%, 0.2 percentage points higher than a year earlier.Reconstructed · data update
    5. Q2 FY2025 WeakenedThe operating margin over the last 4 quarters was 17.1%, 0.1 percentage points higher than a year earlier.Reconstructed · data update
    6. Q1 FY2025 WeakenedThe operating margin over the last 4 quarters was 17.2%, 0.8 percentage points higher than a year earlier.Reconstructed · data update
    7. Q4 FY2024 ConfirmedThe operating margin over the last 4 quarters was 17.1%, 1.1 percentage points higher than a year earlier.Reconstructed · data update
    8. Q3 FY2024 WeakenedThe operating margin over the last 4 quarters was 16.9%, 1.1 percentage points higher than a year earlier.Reconstructed · data update
    9. Q2 FY2024 NewThe operating margin over the last 4 quarters was 17.0%, 1.6 percentage points higher than a year earlier.Reconstructed · initial
  4. Return on equity over the last 4 quarters was 13.5%, against 13.4% a year earlier.

    Newin Q2 FY2026 · first stated
    Rule: Return on equity against a year earlier · Sources 10-Q 2025-06, 10-Q 2026-06, 10-Q 2025-09 and 3 more
    History of this finding, 15 records
    1. Q2 FY2026 NewReturn on equity over the last 4 quarters was 13.5%, against 13.4% a year earlier.Recorded from FY2026Q2_00b71dc7 · data update
    2. Q2 FY2026 RetiredThe finding changed to higher than a year earlier.Recorded from FY2026Q2_00b71dc7 · data update
    3. Q1 FY2026 ConfirmedReturn on equity over the last 4 quarters was 13.5%, against 13.7% a year earlier.Reconstructed · data update
    4. Q4 FY2025 NewReturn on equity over the last 4 quarters was 13.0%, against 13.2% a year earlier.Reconstructed · data update
    5. Q4 FY2025 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    6. Q3 FY2025 NewReturn on equity over the last 4 quarters was 13.1%, against 13.0% a year earlier.Reconstructed · data update
    7. Q3 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    8. Q2 FY2025 NewReturn on equity over the last 4 quarters was 13.4%, against 13.6% a year earlier.Reconstructed · data update
    9. Q2 FY2025 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    10. Q1 FY2025 NewReturn on equity over the last 4 quarters was 13.7%, against 13.7% a year earlier.Reconstructed · data update
    11. Q1 FY2025 RetiredThe finding changed to unchanged from a year earlier.Reconstructed · data update
    12. Q4 FY2024 ConfirmedReturn on equity over the last 4 quarters was 13.2%, against 13.2% a year earlier.Reconstructed · data update
    13. Q3 FY2024 NewReturn on equity over the last 4 quarters was 13.0%, against 13.4% a year earlier.Reconstructed · data update
    14. Q3 FY2024 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    15. Q2 FY2024 NewReturn on equity over the last 4 quarters was 13.6%, against 13.3% a year earlier.Reconstructed · initial
  5. Free cash flow over the last 4 quarters was US$7.3 billion, and operating cash flow was 1.3 times net income attributable to the company.

    Interpretation. Operating cash flow paid for all capital expenditure, and the rest is free for dividends, share buybacks or debt repayment.

    Strengthenedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Free cash flow · Sources 10-Q 2025-06, 10-Q 2025-09, 10-K 2025-12 and 2 more
    History of this finding, 9 records
    1. Q2 FY2026 StrengthenedFree cash flow over the last 4 quarters was US$7.3 billion, and operating cash flow was 1.3 times net income attributable to the company.Recorded from FY2026Q2_00b71dc7 · data update
    2. Q1 FY2026 StrengthenedFree cash flow over the last 4 quarters was US$6.7 billion, and operating cash flow was 1.2 times net income attributable to the company.Reconstructed · data update
    3. Q4 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$6.3 billion, and operating cash flow was 1.2 times net income attributable to the company.Reconstructed · data update
    4. Q3 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$6.1 billion, and operating cash flow was 1.2 times net income attributable to the company.Reconstructed · data update
    5. Q2 FY2025 WeakenedFree cash flow over the last 4 quarters was US$6.2 billion, and operating cash flow was 1.2 times net income attributable to the company.Reconstructed · data update
    6. Q1 FY2025 WeakenedFree cash flow over the last 4 quarters was US$6.7 billion, and operating cash flow was 1.2 times net income attributable to the company.Reconstructed · data update
    7. Q4 FY2024 WeakenedFree cash flow over the last 4 quarters was US$7.3 billion, and operating cash flow was 1.4 times net income attributable to the company.Reconstructed · data update
    8. Q3 FY2024 ConfirmedFree cash flow over the last 4 quarters was US$7.8 billion, and operating cash flow was 1.5 times net income attributable to the company.Reconstructed · data update
    9. Q2 FY2024 NewFree cash flow over the last 4 quarters was US$8.0 billion, and operating cash flow was 1.5 times net income attributable to the company.Reconstructed · initial
  6. Net debt was US$38.5 billion at 27 June 2026, 3.5 times EBITDA over the last 4 quarters.

    Confirmedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Net debt or net cash · Sources 10-Q 2026-06, 10-Q 2025-06, 10-Q 2025-09 and 2 more
    History of this finding, 10 records
    1. Q2 FY2026 ConfirmedNet debt was US$38.5 billion at 27 June 2026, 3.5 times EBITDA over the last 4 quarters.Recorded from FY2026Q2_23849d3f · correction
    2. Q2 FY2026 ConfirmedNet debt was US$38.5 billion at 27 June 2026, 4.1 times EBITDA over the last 4 quarters.Recorded from FY2026Q2_00b71dc7 · data update
    3. Q1 FY2026 StrengthenedNet debt was US$39.9 billion at 28 March 2026, 4.4 times EBITDA over the last 4 quarters.Reconstructed · data update
    4. Q4 FY2025 WeakenedNet debt was US$29.3 billion at 31 December 2025, 3.3 times EBITDA over the last 4 quarters.Reconstructed · data update
    5. Q3 FY2025 StrengthenedNet debt was US$32.1 billion at 27 September 2025, 3.7 times EBITDA over the last 4 quarters.Reconstructed · data update
    6. Q2 FY2025 ConfirmedNet debt was US$28.8 billion at 28 June 2025, 3.4 times EBITDA over the last 4 quarters.Reconstructed · data update
    7. Q1 FY2025 StrengthenedNet debt was US$28.2 billion at 29 March 2025, 3.3 times EBITDA over the last 4 quarters.Reconstructed · data update
    8. Q4 FY2024 WeakenedNet debt was US$25.7 billion at 31 December 2024, 3.0 times EBITDA over the last 4 quarters.Reconstructed · data update
    9. Q3 FY2024 StrengthenedNet debt was US$28.7 billion at 28 September 2024, 3.5 times EBITDA over the last 4 quarters.Reconstructed · data update
    10. Q2 FY2024 NewNet debt was US$26.6 billion at 29 June 2024, 3.2 times EBITDA over the last 4 quarters.Reconstructed · initial

Records before Q2 FY2026 are reconstructed from the latest snapshot. Ledger: findings.json. Correction of 20 October 2026: Annalist left the amortisation of intangible assets that Thermo Fisher Scientific reports on a line of its own out of depreciation and amortisation: US$1.05 billion for 2025 against US$2.78 billion with it. Dividends per share of 6 quarters derived from the figures of 2 filings are no longer published. Records 104 to 106 state the corrected findings: lease-adjusted debt of 3.7 times adjusted EBITDA over the 4 quarters to 27 June 2026, in the significant band, where the aggressive band was stated. Records 6, 7, 21, 30, 32, 45, 54, 64, 74, 76, 87, 96, 99 and 102 cite figures that the correction changed.

Credit, liquidity, earnings quality and score findings: Analysis.

Data

Source documents26 documents, latest Form 10-Q, period ended 27 June 2026List
DownloadsExcel workbook · JSON
SnapshotFY2026Q2_1bcd94e5

Corporate Events

  1. Acquisitions paid in cash31 December 2021

    Paid US$19.4 billion in cash for business acquisitions in fiscal 2021, 28.1% of total assets at the start of the year.

    Source 10-K 2023-12

Earnings, Returns and Balance Sheet

Revenue

By quarter, US dollars

Operating Income

By quarter, US dollars

Net Income Attributable to the Company

By quarter, US dollars

Margins

Last 4 quarters at each quarter end, per cent

Returns

Last 4 quarters, per cent

Free Cash Flow

Operating cash flow less capital expenditure, by quarter, US dollars

Net Debt

Total debt less cash and short-term investments, at quarter end, US dollars

Diluted Earnings per Share

By quarter, as reported

Financial Statements

Figures as filed. Select a figure for its source document and method; a small d marks a quarter derived from cumulative reports.

The statements are loading. They are also available as JSON and CSV.

Ratios

Select a ratio for its formula and the figures it uses, each with its document; (i) gives its definition.

The ratios are loading.

Source Documents

Documents of this snapshot, latest first.

DocumentDateId
Form 10-Q, period ended 27 June 202631 Jul 202610-Q:0000097745-26-000144
Form 10-Q, period ended 28 March 20261 May 202610-Q:0000097745-26-000092
Form 10-K, period ended 31 December 202526 Feb 202610-K:0000097745-26-000018
Form 10-Q, period ended 27 September 202531 Oct 202510-Q:0000097745-25-000159
Form 10-Q, period ended 28 June 20251 Aug 202510-Q:0000097745-25-000101
Form 10-Q, period ended 29 March 20252 May 202510-Q:0000097745-25-000041
Form 10-K, period ended 31 December 202420 Feb 202510-K:0000097745-25-000010
Form 10-Q, period ended 28 September 20241 Nov 202410-Q:0000097745-24-000046
Form 10-Q, period ended 29 June 20242 Aug 202410-Q:0000097745-24-000040
Form 10-Q, period ended 30 March 20243 May 202410-Q:0000097745-24-000023
Form 10-K, period ended 31 December 202322 Feb 202410-K:0000097745-24-000007
Form 10-Q, period ended 30 September 20233 Nov 202310-Q:0000097745-23-000069
Form 10-Q, period ended 1 July 20234 Aug 202310-Q:0000097745-23-000059
Form 10-Q, period ended 1 April 20235 May 202310-Q:0000097745-23-000033
Form 10-K, period ended 31 December 202223 Feb 202310-K:0000097745-23-000008
Form 10-Q, period ended 1 October 20224 Nov 202210-Q:0000097745-22-000057
Form 10-Q, period ended 2 July 20225 Aug 202210-Q:0000097745-22-000047
Form 10-Q, period ended 2 April 20226 May 202210-Q:0000097745-22-000027
Form 10-K, period ended 31 December 202124 Feb 202210-K:0000097745-22-000011
Form 10-Q, period ended 2 October 20214 Nov 202110-Q:0000097745-21-000058
Form 10-Q, period ended 3 July 20216 Aug 202110-Q:0000097745-21-000045
Form 10-Q, period ended 3 April 20217 May 202110-Q:0000097745-21-000026
Form 10-K, period ended 31 December 202025 Feb 202110-K:0000097745-21-000011
Form 10-Q, period ended 26 September 202030 Oct 202010-Q:0000097745-20-000051
Form 10-Q, period ended 27 June 202031 Jul 202010-Q:0000097745-20-000038
Form 10-Q, period ended 28 March 20201 May 202010-Q:0000097745-20-000018

Checks

254253 of 254 checks passed, 1 warning
Fiscal calendar68 passedFiscal years last 350 to 380 days, quarters 80 to 125 days, and each period starts on the day after the one before. Checked at error level.
Quarters and fiscal year125 passedThe 4 quarters of every item add up to its fiscal year, or a later filing restated the year. Checked at error level.
Withheld values1 value withheldA value that contradicts the definition of its item, or that documents report in contradiction, is withheld. Checked at warning level.
Proceeds from issuance of long-term debt, Q2 FY2024: withheld, negative where the item cannot be negative
Filer identity1 passedThe documents are those of the company of this page. Checked at error level.
Balance sheet identity26 passedTotal assets equal total liabilities and equity at each balance sheet date. Checked at error level.
Lease liabilities6 passedLease payments due, less imputed interest, equal the lease liabilities. Checked at warning level.
Debt maturities6 passedThe debt maturity schedule adds up to the long-term debt. Checked at warning level.
Quarters and 9 months15 passedThe 3 reported quarters of a fiscal year add up to the reported 9-month figure. Checked at error level.
Earnings per share6 passedNet income divided by average shares agrees with reported basic earnings per share. Checked at warning level.

Data Quality

How many values of this snapshot the checks prove, and how many Annalist derives, withholds and tracks as restated. Every company.

Values published1,412
Proven by a check47.9%, 677 values
Confirmed by a second document0.0%, 0 values
Derived from reported figures20.3%, 287 values
Values withheld1
Restated figures tracked0
Changes compared on one basis0
Company lines mapped0 of 0 reviewed

Citation

Annalist, Thermo Fisher Scientific Inc., snapshot thermo-fisher/FY2026Q2_1bcd94e5 (as of FY2026 Q2); <item label>, <period>; source <document id> (<document url>)

Snapshot FY2026Q2_1bcd94e5 · dataset SHA-256 1bcd94e5e27120e8ab504c5f2ea2224b77a3314b76a7cff1d4ea09991493850f · findings rules 0.4

Data: info.json · dataset.json · validation.json · documents.json